4.7 Article

The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

期刊

NATURE IMMUNOLOGY
卷 16, 期 8, 页码 859-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3202

关键词

-

资金

  1. French National Research Agency (Investissements d'Avenir program) [ANR-11-LABX-0021]
  2. Ligue nationale contre le cancer
  3. Fondation de France
  4. Institut National du Cancer
  5. Fondation ARC
  6. Conseil Regional de Bourgogne/INSERM
  7. French National Research Agency [ANR-13-JSV3-0001]
  8. Fondation pour l'aide a la Recherche sur la Sclerose en Plaques
  9. Ligue Regionale contre le cancer Comite Grand-Est
  10. European Commission [PCIG10-GA-2011-303719]
  11. Centre National de la Recherche Scientifique
  12. Fonds Europeen de Developpement Economique et Regional
  13. Le Stadium
  14. Orleans and Fondation pour la Recherche Medicale
  15. Agence Nationale de la Recherche (ANR) [ANR-13-JSV3-0001] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

The receptor NLRP3 is involved in the formation of the NLRP3 inflammasome that activates caspase-1 and mediates the release of interleukin 1 beta (IL-1 beta) and IL-18. Whether NLRP3 can shape immunological function independently of inflammasomes is unclear. We found that NLRP3 expression in CD4(+) T cells specifically supported a T helper type 2 (T(H)2) transcriptional program in a cell-intrinsic manner. NLRP3, but not the inflammasome adaptor ASC or caspase-1, positively regulated a T(H)2 program. In T(H)2 cells, NLRP3 bound the Il4 promoter and transactivated it in conjunction with the transcription factor IRF4. Nlrp3-deficient T(H)2 cells supported melanoma tumor growth in an IL-4-dependent manner and also promoted asthma-like symptoms. Our results demonstrate the ability of NLRP3 to act as a key transcription factor in T(H)2 differentiation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据